Search
for
Sort by
Research 241–270 of 926
- Focal Asymptomatic Hair Loss in an Adolescent: A Case Report
- A Contemporary View on Felix Pinkus’ Concept of the Vitreous Membrane
- Issue Information
- A Case of Gynecomastia Induced by Use of Doxazosin
- Minoxidil
- A Filipino with Systemic Lupus Erythematosus-Scleroderma Overlap Syndrome
- Androgen Secreting Steroid Cell Tumor of the Ovary Represented with Postmenopasal Bleeding and Extensive Hirsutism
- Registrars’ Symposium: Summaries of Papers
- Prevention of Temporal Alopecia Following Rhytidectomy
- Abstracts
- The urine as a diagnostic key for a homozygous EGFR mutation
- Split skin graft “from scalp to scalp” for repairing large surgical defects
- Trichoscopy: A Useful Tool in Diagnosing Temporal Triangular Alopecia
- Congenital Triangular Alopecia
- Use of chemotherapy during human pregnancy
- The Rotterdam Study: 2018 update on objectives, design and main results
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
- Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice
- Prostaglandin-Induced Hair Growth
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Severe Acute Respiratory Syndrome Among Children
- Extrapulmonary disorders associated with Rhodococcus equi infection in foals: 150 cases (1987–2007)
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- MINOXIDIL IN RESISTANT HYPERTENSION
- Neural Mechanisms of Hair Growth Control
- Beyond acne: Current aspects of sebaceous gland biology and function
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia